Rapid Micro Biosystems, Inc. (RPID)
0.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
Rapid Micro Biosystems Debt to Equity Ratio : 1.315 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.315 |
| March 31, 2026 | 1.162 |
| December 31, 2025 | 0.719 |
| September 30, 2025 | 0.5438 |
| June 30, 2025 | 0.1023 |
| March 31, 2025 | 0.0897 |
| December 31, 2024 | 0.0819 |
| September 30, 2024 | 0.0765 |
| June 30, 2024 | 0.0718 |
| March 31, 2024 | 0.0667 |
| December 31, 2023 | 0.0623 |
| September 30, 2023 | 0.0575 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0534 |
| March 31, 2023 | 0.0506 |
| December 31, 2022 | 0.0485 |
| September 30, 2022 | 0.0459 |
| June 30, 2022 | 0.0434 |
| March 31, 2022 | 0.0387 |
| December 31, 2021 | 0.0018 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.3502 |
| March 31, 2021 | 0.3006 |
| December 31, 2020 | 0.9996 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Lifecore Biomedical, Inc. | 9.717 |
| Repligen Corp. | 0.3271 |
| Bio-Techne Corp. | 0.1371 |
| Codexis, Inc. | 2.202 |
| MetaStat, Inc. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 58.45M |
| Total Liabilities (Quarterly) | 40.70M |
| Shareholders Equity (Quarterly) | 17.75M |
| Current Ratio | 2.521 |
| Net Debt Paydown Yield | -4.04% |